0

Coronary Risk Factors Collection
 121-140 of 164 Articles
ACP Journal Club |  19 May 2009
What kind of randomized trials do patients and clinicians need?
Merrick Zwarenstein, MBBCh, MSc; Shaun Treweek, PhD
Ann Intern Med. 2009;150(10):JC5-2. doi:10.7326/0003-4819-150-10-200905190-02002
ACP Journal Club |  19 May 2009
Benazepril plus amlodipine reduced cardiovascular risk more than benazepril plus hydrochlorothiazide
Simon W. Rabkin, MD
Ann Intern Med. 2009;150(10):JC5-8. doi:10.7326/0003-4819-150-10-200905190-02008
ACP Journal Club |  19 May 2009
Intensive primary care treatment reduced cardiovascular risk factors at 1 year in screen-detected type 2 diabetes
C. Raina Elley, MD; Tim Kenealy, MD, PhD
Ann Intern Med. 2009;150(10):JC5-9. doi:10.7326/0003-4819-150-10-200905190-02009
ACP Journal Club |  19 May 2009
Irbesartan did not reduce all-cause death or CV hospitalization in heart failure and preserved ejection fraction
Justin A. Ezekowitz, MD; Finlay A. McAlister, MD
Ann Intern Med. 2009;150(10):JC5-10. doi:10.7326/0003-4819-150-10-200905190-02010
ACP Journal Club |  21 April 2009
Review: Statins are effective for prevention of cardiovascular events in patients without coronary heart disease
Finlay A. McAlister, MD
Ann Intern Med. 2009;150(8):JC4-5. doi:10.7326/0003-4819-150-8-200904210-02005
ACP Journal Club |  21 April 2009
Review: Metformin reduces risk for CV mortality compared with other oral diabetes drugs or placebo in type 2 diabetes
Lorraine Lipscombe, MD, MSc, FRCPC
Ann Intern Med. 2009;150(8):JC4-8. doi:10.7326/0003-4819-150-8-200904210-02008
ACP Journal Club |  21 April 2009
Review: Oral drugs for gestational diabetes do not increase adverse maternal and neonatal outcomes more than insulin
Denice Feig, MD
Ann Intern Med. 2009;150(8):JC4-9. doi:10.7326/0003-4819-150-8-200904210-02009
ACP Journal Club |  17 March 2009
Intensive and standard glucose control did not differ for major CV events or death in poorly controlled type 2 diabetes
Gillian L. Booth, MD, MSc
Ann Intern Med. 2009;150(6):JC3-8. doi:10.7326/0003-4819-150-6-200903170-02008
ACP Journal Club |  17 March 2009
Reynolds Risk Score for men predicted cardiovascular events more accurately than traditional risk factors only
Keane K. Lee, MD; Mark A. Hlatky, MD
Ann Intern Med. 2009;150(6):JC3-14. doi:10.7326/0003-4819-150-6-200903170-02014
ACP Journal Club |  17 February 2009
Telmisartan did not reduce a composite of CV death, MI, HF, or stroke in high-risk patients intolerant to ACE inhibitors
Robin J. Taylor, MD
Ann Intern Med. 2009;150(4):JC2-6. doi:10.7326/0003-4819-150-4-200902170-02006
ACP Journal Club |  17 February 2009
Telmisartan did not prevent recurrent stroke or major cardiovascular events
Michael A. Sloan, MD, MS
Ann Intern Med. 2009;150(4):JC2-9. doi:10.7326/0003-4819-150-4-200902170-02009
ACP Journal Club |  17 February 2009
Intensive insulin therapy reduced long-term risk for incident hypertension in type 1 diabetes
Apostolos Tsapas, MD, PhD
Ann Intern Med. 2009;150(4):JC2-12. doi:10.7326/0003-4819-150-4-200902170-02012
ACP Journal Club |  20 January 2009
Applying evidence: What’s the next action?
Paul Glasziou, MD
Ann Intern Med. 2009;150(2):JC1-2. doi:10.7326/0003-4819-150-2-200901200-02002
ACP Journal Club |  20 January 2009
Rosuvastatin prevented major cardiovascular events in persons with elevated C-reactive protein
Denise L. Campbell-Scherer, MD, PhD; Victor M. Montori, MD, MSc
Ann Intern Med. 2009;150(2):JC1-4. doi:10.7326/0003-4819-150-2-200901200-02004
ACP Journal Club |  20 January 2009
Aspirin and/or antioxidants did not prevent CV events in diabetes and peripheral arterial disease
Michael E. Farkouh, MD, MSc
Ann Intern Med. 2009;150(2):JC1-8. doi:10.7326/0003-4819-150-2-200901200-02008
ACP Journal Club |  20 January 2009
Pioglitazone reduced liver injury and improved fasting glucose in nonalcoholic steatohepatitis without diabetes
Kristina Utzschneider, MD; Kris Kowdley, MD
Ann Intern Med. 2009;150(2):JC1-9. doi:10.7326/0003-4819-150-2-200901200-02009
ACP Journal Club |  20 January 2009
n-3 polyunsaturated fatty acids reduced morbidity and mortality in chronic heart failure
James M. Brophy, MD, PhD
Ann Intern Med. 2009;150(2):JC1-11. doi:10.7326/0003-4819-150-2-200901200-02011
ACP Journal Club |  16 December 2008
Benefits of early intensive glucose control to prevent diabetes complications were sustained for up to 10 years
Eoin P. O’Sullivan, MD; Sean F. Dinneen, MD
Ann Intern Med. 2008;149(12):JC6-4. doi:10.7326/0003-4819-149-12-200812160-02004
ACP Journal Club |  16 December 2008
Benefits of tight blood pressure control to prevent diabetes complications were not sustained
Eoin P. O’Sullivan, MD; Sean F. Dinneen, MD
Ann Intern Med. 2008;149(12):JC6-5. doi:10.7326/0003-4819-149-12-200812160-02005
ACP Journal Club |  16 December 2008
A combination of telmisartan and ramipril increased renal outcomes in vascular disease or diabetes
Arsh K. Jain, MD; Matthew A. Weir, MD
Ann Intern Med. 2008;149(12):JC6-7. doi:10.7326/0003-4819-149-12-200812160-02007
Advertisement

Buy This Article

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)